drugset
drugset / Trial / NCT04488978

Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension

NCT04488978 ↗

Phase 2 Completed 440 enrolled Handok Inc.
RandomizedFactorialQuadruple-blindTreatment

Summary

A Randomized, Double-blind, Multicenter, Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypertension

Timeline

Start
2020-05-21
Primary completion
2021-11-09
Completion
2021-11-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified — —
Subject Irbesartan Small molecule — —

Indications

essential hypertension